XML 62 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended 28 Months Ended 34 Months Ended 164 Months Ended
Jun. 30, 2012
Successor
Jun. 30, 2011
Successor
Jun. 30, 2012
Successor
Jun. 30, 2011
Successor
Dec. 31, 2011
Successor
Dec. 31, 2010
Successor
Dec. 31, 2011
Successor
Jun. 30, 2012
Successor
Aug. 31, 2009
Predecessor
Revenue                  
Product sales $ 28,283 $ 0 $ 44,391 $ 0 $ 0 $ 0 $ 0 $ 44,391 $ 1,390,112
License fees     0 0 0 0 0 0 260,000
Total revenue 28,283 0 44,391 0 0 0 0 44,391 1,650,112
Cost of sales 2,094,574 0 3,647,306 0 12,796 0 12,796 3,660,103 402,458
Gross profit (loss) (2,066,291) 0 (3,602,915) 0 (12,796) 0 (12,796) (3,615,712) 1,247,654
Selling, general and administrative expenses 3,238,775 3,176,072 6,962,087 5,441,089 12,795,476 6,105,352 21,464,920 28,427,007 77,118,046
Research and development expenses 388,171 1,601,665 867,735 3,218,194 7,170,520 5,486,319 14,480,035 15,347,770 56,250,327
Operating loss (5,693,237) (4,777,737) (11,432,737) (8,659,283) (19,978,792) (11,591,671) (35,957,751) (47,390,489) (132,120,719)
Other income (expense)                  
Interest income     0 0 0 0 1 1 6,973,954
Reorganization items, net     0 0 0 3,303 (69,174) (69,174) 72,850,160
Other income     0 0 0 244,479 244,479 244,479 316,338
Warrant income (expense) 3,148,000 (3,510,552) 2,647,000 (9,806,882) (4,762,694) (465,232) (5,547,010) (2,900,010) 0
Derivative revaluation (expense) (1,951,364) (1,561,412) (1,917,322) (8,182,138) (5,451,518) 0 (5,451,518) (7,368,840) 0
Interest expense (197,156) (283,661) (445,943) (557,069) (1,061,862) (1,045,199) (2,354,235) (2,800,178) (18,790,218)
Loss on extinguishment of debt (4,421,184) 0 (4,421,184) 0       (4,421,184) 0
Loss from continuing operations before income taxes (9,114,941) (10,133,362) (15,570,186) (27,205,372) (31,254,866) (12,854,320) (49,135,208) (64,705,395) (70,770,485)
Income tax benefit 54,348 0 108,695 0 0 0 0 108,696 0
Loss from continuing operations (9,060,593) (10,133,362) (15,461,491) (27,205,372) (31,254,866) (12,854,320) (49,135,208) (64,596,699) (70,770,485)
Income (loss) from discontinued operations, net of tax 863 32,166 (5,708) 41,462 (94,475) (25,313) (128,271) (133,979) (46,351,159)
Net loss     (15,467,199) (27,163,910) (31,349,341) (12,879,633) (49,263,479) (64,730,678) (117,121,644)
Deemed dividend associated with beneficial conversion     0 0 0 0 0 0 (11,423,824)
Preferred stock dividends     0 0 0 0 0 0 (1,589,861)
Net loss (9,059,730) (10,101,196) (15,467,199) (27,163,910) (31,349,341) (12,879,633) (49,263,479) (64,730,678) (130,135,329)
Per share information:                  
Loss from continuing operations-basic and diluted $ (0.09) $ (0.32) $ (0.16) $ (1.02) $ (0.57) $ (0.69) $ (1.46) $ (1.45) $ (3.97)
Loss from discontinued operations-basic and diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ (2.65)
Deemed dividend associated with beneficial conversion of preferred stock     $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ (0.65)
Preferred stock dividends     $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ (0.09)
Net loss per common share - basic and diluted $ (0.09) $ (0.32) $ (0.16) $ (1.02) $ (0.57) $ (0.69) $ (1.46) $ (1.45) $ (7.36)
Comprehensive loss         $ (31,349,341) $ (12,879,633) $ (49,349,479)    
Weighted average number of basic and diluted common shares outstanding 96,798,109 31,825,735 96,307,412 26,557,261 54,857,520 18,757,756 33,664,124 44,722,395 17,678,219